These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19361499)

  • 1. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinpramine--a promising compound for treating immune-mediated demyelination of the nervous system.
    Meyer zu Hörste G; Mausberg AK; Korth C; Stüve O; Kieseier BC
    Drug News Perspect; 2010 Jun; 23(5):287-94. PubMed ID: 20603652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE.
    Dijkstra S; Kooij G; Verbeek R; van der Pol SM; Amor S; Geisert EE; Dijkstra CD; van Noort JM; Vries HE
    Neurobiol Dis; 2008 Sep; 31(3):413-21. PubMed ID: 18586096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the evidence for multiple sclerosis as an autoimmune disease.
    Altmann D
    Arch Neurol; 2005 Apr; 62(4):688; author reply 688-9. PubMed ID: 15824275
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis and related disorders: evolving pathophysiologic insights.
    Bar-Or A
    Lancet Neurol; 2016 Jan; 15(1):9-11. PubMed ID: 26700897
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
    J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental autoimmune encephalomyelitis].
    Cornet A; Vizler C; Liblau R
    Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
    J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for multiple sclerosis.
    Owens T
    Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D; Sela M; Arnon R
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
    Szczepanik M; Tutaj M; Filipczak-Bryniarska I; Bryniarski K
    Przegl Lek; 2005; 62(2):115-8. PubMed ID: 16095157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic constraints imposed by the blood-brain barrier: the example of multiple sclerosis].
    Jolliet P
    Rev Neurol (Paris); 2000 Jul; 156(6-7):681-3. PubMed ID: 10891808
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental models of multiple sclerosis.
    Pachner AR
    Curr Opin Neurol; 2011 Jun; 24(3):291-9. PubMed ID: 21519255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinpramine is a novel compound effective in ameliorating brain autoimmune disease.
    Singh MP; Meyer zu Hörste G; Hu W; Mausberg AK; Cravens PD; Eagar T; Löber S; Klingenstein R; Gmeiner P; Korth C; Kieseier BC; Stüve O
    Exp Neurol; 2009 Feb; 215(2):397-400. PubMed ID: 18996373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current data on the etiopathogenesis of multiple sclerosis].
    Duca E
    Neurol Psihiatr Neurochir; 1972; 17(5):385-94. PubMed ID: 4632587
    [No Abstract]   [Full Text] [Related]  

  • 18. Futility of the autoimmune orthodoxy in multiple sclerosis research.
    Behan PO
    Expert Rev Neurother; 2010 Jul; 10(7):1023-5. PubMed ID: 20586684
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis: trapped in deadly glue.
    Platten M; Steinman L
    Nat Med; 2005 Mar; 11(3):252-3. PubMed ID: 15746934
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
    Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
    J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.